Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062822-26-000031
Filing Date
2026-02-23
Accepted
2026-02-23 07:49:43
Documents
1
Period of Report
2026-02-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 8097
  Complete submission text file 0001062822-26-000031.txt   9800
Mailing Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
DEBBANE RAYMOND (Reporting) CIK: 0001053890 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30111 | Film No.: 26662117

Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Issuer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)